1. Challenges in the Evaluation of Emerging Highly Specialised Technologies: Is There a Role for Living HTA?

   • Tracy Merlin
   • Jackie Street
   • Hossein Haji Ali Afzali

   Current Opinion Open access 12 October 2023 Pages: 823 - 830

   

2. Drug Repurposing of Generic Drugs: Challenges and the Potential Role for Government

   • Karel H. van der Pol
   • Mohamad Aljofan
   • Michael Spedding

   Current Opinion Open access 03 July 2023 Pages: 831 - 840

3. Economic Evaluations of Imaging Biomarker-Driven Companion Diagnostics for Cancer: A Systematic Review

   • Sibo Liu
   • Daniel SW Tan
   • Ann-Marie Chacko

   Systematic Review 25 September 2023 Pages: 841 - 855

   

4. Is Using Sodium-Glucose Cotransporter-2 Inhibitors to Treat Adults with Chronic Heart Failure Cost-Effective? A Systematic Review of Cost-Effectiveness Studies

   • Yi Jing Tan
   • Siew Chin Ong
   • Ying Min Kan

   Systematic Review 30 August 2023 Pages: 857 - 875

   

5. Projected Impact on Labour Productivity Costs of Cancer-Related Premature Mortality in Europe 2018–2040

   • Marta Ortega-Ortega
   • Paul Hanly
   • Linda Sharp

   Original Research Article Open access 08 August 2023 Pages: 877 - 889

6. Evaluating the Short-Term Costs and Benefits of a Nationwide Diabetes Prevention Programme in England: Retrospective Observational Study

   • Emma McManus
   • Rachel Meacock
   • Matt Sutton

   Original Research Article Open access 03 October 2023 Pages: 891 - 903

7. Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices

   • Aniek Dane
   • Anne-Sophie Klein Gebbink
   • Carin A. Uyl-de Groot

   Original Research Article Open access 26 September 2023 Pages: 905 - 914

   

8. Direct Medical Costs of COPD in the USA: An Analysis of the Medical Expenditure Panel Survey 2017–2018

   • Chintal H. Shah
   • Robert M. Reed
   • Zafar Zafari

   Original Research Article 03 June 2023 Pages: 915 - 924

   

9. The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022

   • Michela Meregaglia
   • Francesco Malandrini
   • Oriana Ciani

   Original Research Article Open access 02 September 2023 Pages: 925 - 935

   

10. Child–Parent Agreement in the Assessment of Health-Related Quality of Life Using the CHU9D and the PedsQL^TM

    • Diana Khanna
    • Jyoti Khadka
    • in Collaboration with the Quality of Life in Kids: Key Evidence to Strengthen Decisions in 6 Australia (QUOKKA) Project Team

    Original Research Article Open access 29 September 2023 Pages: 937 - 947

    

11. Psychometric Evaluation of the PedsQL GCS and CHU9D in Australian Children and Adolescents with Common Chronic Health Conditions

    • Rakhee Raghunandan
    • Kirsten Howard
    • Alison Hayes

    Original Research Article Open access 03 October 2023 Pages: 949 - 965

    

12. Correction: Deterministic and Probabilistic Analysis of a Simple Markov Model: How Different Could They Be?

    • Howard Thom

    Correction Open access 27 September 2023 Pages: 967 - 967